Return On Equity of Bone Biologics Corp from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bone Biologics Corp quarterly and annual Return On Equity in % history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Bone Biologics Corp Return On Equity for the quarter ending 30 Sep 2025 was -83%, a 33% increase year-over-year.
  • Bone Biologics Corp annual Return On Equity for 2024 was -119%, a 50% increase from 2023.
  • Bone Biologics Corp annual Return On Equity for 2023 was -236%, a 773% decline from 2022.
  • Bone Biologics Corp annual Return On Equity for 2022 was -27%, a 256% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Bone Biologics Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -83% +42% +33% 01 Jul 2025 30 Sep 2025
Q2 2025 -101% +54% +35% 01 Apr 2025 30 Jun 2025
Q1 2025 -130% +22% +14% 01 Jan 2025 31 Mar 2025
Q4 2024 -119% +117% +50% 01 Oct 2024 31 Dec 2024
Q3 2024 -125% +18% +13% 01 Jul 2024 30 Sep 2024
Q2 2024 -154% -31% -25% 01 Apr 2024 30 Jun 2024
Q1 2024 -152% -56% -58% 01 Jan 2024 31 Mar 2024
Q4 2023 -236% -209% -773% 01 Oct 2023 31 Dec 2023
Q3 2023 -143% -98% -216% 01 Jul 2023 30 Sep 2023
Q2 2023 -123% +117% +49% 01 Apr 2023 30 Jun 2023
Q1 2023 -96% -140% -321% 01 Jan 2023 31 Mar 2023
Q4 2022 -27% -44% -256% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% -58% -445% 01 Jul 2022 30 Sep 2022
Q2 2022 -240% -253% -1985% 01 Apr 2022 30 Jun 2022
Q1 2022 44% +31% +254% 01 Jan 2022 31 Mar 2022
Q4 2021 17% +3.3% +24% 01 Oct 2021 31 Dec 2021
Q3 2021 13% -2% -13% 01 Jul 2021 30 Sep 2021
Q2 2021 13% -4.3% -25% 01 Apr 2021 30 Jun 2021
Q1 2021 12% -10% -45% 01 Jan 2021 31 Mar 2021
Q4 2020 14% -17% -55% 01 Oct 2020 31 Dec 2020
Q3 2020 15% -28% -65% 01 Jul 2020 30 Sep 2020
Q2 2020 17% -27% -61% 01 Apr 2020 30 Jun 2020
Q1 2020 22% -27% -55% 01 Jan 2020 31 Mar 2020
Q4 2019 31% -21% -41% 01 Oct 2019 31 Dec 2019
Q3 2019 43% -26% -37% 01 Jul 2019 30 Sep 2019
Q2 2019 44% -42% -49% 01 Apr 2019 30 Jun 2019
Q1 2019 50% -11% -18% 01 Jan 2019 31 Mar 2019
Q4 2018 52% -26% -33% 01 Oct 2018 31 Dec 2018
Q3 2018 68% -31% -31% 01 Jul 2018 30 Sep 2018
Q2 2018 86% -46% -35% 01 Apr 2018 30 Jun 2018
Q1 2018 61% -171% -74% 01 Jan 2018 31 Mar 2018
Q4 2017 78% -354% -82% 01 Oct 2017 31 Dec 2017
Q3 2017 100% -491% -83% 01 Jul 2017 30 Sep 2017
Q2 2017 132% -623% -83% 01 Apr 2017 30 Jun 2017
Q1 2017 232% -700% -75% 01 Jan 2017 31 Mar 2017
Q4 2016 433% -35% -7.4% 01 Oct 2016 31 Dec 2016
Q3 2016 590% +346% +141% 01 Jul 2016 30 Sep 2016
Q2 2016 755% +571% +311% 01 Apr 2016 30 Jun 2016
Q1 2016 931% +810% +664% 01 Jan 2016 31 Mar 2016
Q4 2015 467% +344% +278% 01 Oct 2015 31 Dec 2015
Q3 2015 245% +162% +195% 01 Jul 2015 30 Sep 2015
Q2 2015 183% +150% +451% 01 Apr 2015 30 Jun 2015
Q1 2015 122% +61% +101% 01 Jan 2015 31 Mar 2015
Q4 2014 124% +85% +223% 01 Oct 2014 31 Dec 2014
Q3 2014 83% +37% +82% 01 Jul 2014 30 Sep 2014
Q2 2014 33% 01 Apr 2014 30 Jun 2014
Q1 2014 61% 01 Jan 2014 31 Mar 2014
Q4 2013 38% 01 Nov 2013 31 Jan 2014
Q3 2013 46% 01 Jul 2013 30 Sep 2013

Bone Biologics Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -119% +117% +50% 01 Jan 2024 31 Dec 2024
2023 -236% -209% -773% 01 Jan 2023 31 Dec 2023
2022 -27% -44% -256% 01 Jan 2022 31 Dec 2022
2021 17% +3.3% +24% 01 Jan 2021 31 Dec 2021
2020 14% -17% -55% 01 Jan 2020 31 Dec 2020
2019 31% -21% -41% 01 Jan 2019 31 Dec 2019
2018 52% -26% -33% 01 Jan 2018 31 Dec 2018
2017 78% -354% -82% 01 Jan 2017 31 Dec 2017
2016 433% -35% -7.4% 01 Jan 2016 31 Dec 2016
2015 467% +344% +278% 01 Jan 2015 31 Dec 2015
2014 124% +48% +64% 01 Jan 2014 31 Dec 2014
2013 76% +16% +26% 01 Jan 2013 31 Dec 2013
2012 60% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.